Hospital
The University of Chicago Medical Center
The University of Chicago Medical Center was paid $3.47M by Medicaid between Jan 2018 and May 2024, across 227 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 33% of everything it billed.
33Billing provider infoTHE UNIVERSITY OF CHICAGO MEDICAL CENTER
CHICAGO, IL 60637
CHICAGO, IL 60637
33aNPI1508956509assigned 10/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.47M
24GClaims272,017
24DCodes billed227
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#10 of 129
Median peer was paid$547K
This provider vs. median6.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 74,211 | $1.01M | |
| 2019 | 152,193 | $1.84M | |
| 2020 | 42,786 | $595K | |
| 2021 | 60 | $55.80 | |
| 2022 | 61 | $610.22 | |
| 2023 | 102 | $122.10 | |
| 2024incomplete | 2,604 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 33% | 11,851 | 4,463 | $1.15M |
| 97161 | 5.8% | 1,857 | 1,597 | $202K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 4.2% | 1,623 | 1,270 | $147K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 1,574 | 1,205 | $118K |
| 99245 | 3.2% | 917 | 720 | $111K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.0% | 2,317 | 1,650 | $105K |
| 99243 | 2.3% | 1,041 | 935 | $79K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.3% | 4,431 | 1,670 | $79K |
| 97162 | 2.2% | 708 | 560 | $77K | |
| 80053 | Comprehensive metabolic panel | 2.0% | 20,765 | 13,185 | $68K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 899 | 474 | $58K |
| 94010 | 1.6% | 2,208 | 1,317 | $56K |
215 more codes
| 90686 | 1.6% | 4,974 | $56K | |
| 87536 | 1.4% | 1,287 | $50K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.3% | 1,120 | $47K |
| 99205 | Prolong outpt/office vis | 1.1% | 557 | $38K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.1% | 249 | $38K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.0% | 2,604 | $36K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.0% | 2,609 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,432 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,283 | $31K |
| 90715 | <1% | 1,594 | $29K | |
| 93798 | <1% | 908 | $23K | |
| 86480 | <1% | 1,095 | $22K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,314 | $21K |
| 96415 | <1% | 1,505 | $21K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 423 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,995 | $19K |
| L3808 | Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment | <1% | 54 | $19K |
| 87522 | Neg quan hep c or qual rna | <1% | 806 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,359 | $18K |
| 87390 | <1% | 2,090 | $18K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 17 | $16K |
| 90670 | <1% | 255 | $16K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,272 | $15K |
| L3906 | Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment | <1% | 43 | $14K |
| 92134 | <1% | 871 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 318 | $13K |
| 87497 | <1% | 711 | $12K | |
| 87799 | <1% | 637 | $11K | |
| 83970 | <1% | 794 | $11K | |
| 97165 | <1% | 842 | $11K | |
| 85027 | <1% | 6,785 | $10K | |
| 83735 | <1% | 4,941 | $10K | |
| 86780 | <1% | 2,334 | $10K | |
| 86334 | <1% | 787 | $10K | |
| 90656 | <1% | 786 | $10K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 240 | $9K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,655 | $9K |
| 90732 | <1% | 264 | $9K | |
| 73630 | <1% | 812 | $9K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 390 | $8K |
| 73564 | <1% | 769 | $8K | |
| 92557 | <1% | 223 | $8K | |
| 83880 | <1% | 1,371 | $8K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 745 | $8K |
| 73610 | <1% | 472 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,137 | $7K |
| 73130 | <1% | 885 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,730 | $7K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 326 | $7K |
| 85610 | <1% | 5,679 | $7K | |
| 86803 | <1% | 1,418 | $7K | |
| 86701 | <1% | 2,064 | $7K | |
| 87517 | <1% | 320 | $7K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 490 | $6K |
| 82784 | <1% | 2,400 | $6K | |
| 87340 | <1% | 1,929 | $6K | |
| 80197 | <1% | 1,587 | $6K | |
| 92015 | Determination of refractive state | <1% | 391 | $6K |
| 73502 | <1% | 467 | $6K | |
| 80061 | Lipid panel | <1% | 3,489 | $6K |
| 83615 | <1% | 3,348 | $6K | |
| 82607 | <1% | 1,507 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 374 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,571 | $5K |
| 86702 | <1% | 2,075 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,036 | $5K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 706 | $5K |
| 96402 | <1% | 477 | $5K | |
| 73562 | <1% | 559 | $5K | |
| 73030 | <1% | 420 | $5K | |
| 94760 | <1% | 1,935 | $5K | |
| 82728 | <1% | 2,716 | $5K | |
| 83550 | <1% | 2,146 | $5K | |
| 96417 | <1% | 279 | $5K | |
| 82378 | <1% | 1,026 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 852 | $4K |
| 81003 | <1% | 5,560 | $4K | |
| 84439 | <1% | 2,171 | $4K | |
| 86706 | <1% | 1,178 | $4K | |
| 82570 | <1% | 2,897 | $4K | |
| 97803 | <1% | 114 | $4K | |
| 82962 | <1% | 6,010 | $4K | |
| 84100 | <1% | 3,124 | $4K | |
| 86140 | <1% | 3,088 | $4K | |
| L4386 | Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 33 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 180 | $4K |
| 72110 | <1% | 166 | $4K | |
| 86225 | <1% | 786 | $4K | |
| 86160 | <1% | 1,239 | $3K | |
| 83883 | <1% | 894 | $3K | |
| 86704 | <1% | 770 | $3K | |
| 83540 | <1% | 2,246 | $3K | |
| 80076 | <1% | 1,472 | $3K | |
| 77066 | Tomosynthesis, mammo | <1% | 42 | $3K |
| 82105 | <1% | 553 | $3K | |
| 84702 | <1% | 876 | $3K | |
| 86850 | <1% | 1,917 | $3K | |
| 99242 | <1% | 75 | $3K | |
| 84165 | <1% | 874 | $3K | |
| 84403 | <1% | 280 | $3K | |
| 83037 | <1% | 4,837 | $3K | |
| 86901 | <1% | 2,178 | $3K | |
| 84153 | <1% | 540 | $3K | |
| 73110 | <1% | 241 | $3K | |
| 92083 | <1% | 122 | $2K | |
| 83021 | <1% | 553 | $2K | |
| 86360 | <1% | 1,106 | $2K | |
| 72100 | <1% | 139 | $2K | |
| 81001 | <1% | 2,897 | $2K | |
| 80069 | <1% | 836 | $2K | |
| 96910 | <1% | 226 | $2K | |
| 86146 | <1% | 222 | $2K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 167 | $2K |
| 86900 | <1% | 2,178 | $2K | |
| 95800 | <1% | 17 | $2K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 883 | $2K |
| 84480 | <1% | 855 | $2K | |
| 84550 | <1% | 1,384 | $2K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 49 | $2K |
| 86235 | <1% | 621 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 35 | $2K |
| 84703 | <1% | 619 | $2K | |
| 82043 | <1% | 1,379 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 142 | $2K |
| 85046 | <1% | 926 | $1K | |
| 85652 | <1% | 2,031 | $1K | |
| 84156 | <1% | 2,147 | $1K | |
| 88321 | <1% | 264 | $1K | |
| 87631 | <1% | 26 | $1K | |
| 85730 | <1% | 615 | $1K | |
| 96416 | <1% | 72 | $1K | |
| 82746 | <1% | 438 | $1K | |
| 84630 | <1% | 452 | $1K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 42 | $1K |
| 87186 | <1% | 243 | $1K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 51 | $988.90 |
| 86708 | <1% | 420 | $960.88 | |
| 86147 | <1% | 222 | $852.84 | |
| 83690 | <1% | 405 | $843.88 | |
| 84446 | <1% | 358 | $729.01 | |
| 86301 | <1% | 98 | $718.08 | |
| 84425 | <1% | 155 | $717.60 | |
| 20550 | <1% | 21 | $710.49 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 877 | $660.91 |
| 92567 | <1% | 45 | $650.76 | |
| 93296 | <1% | 58 | $629.13 | |
| 82550 | <1% | 361 | $628.04 | |
| 92250 | <1% | 26 | $608.25 | |
| 83951 | <1% | 41 | $598.50 | |
| 86255 | <1% | 316 | $549.95 | |
| 82950 | <1% | 465 | $549.46 | |
| 92550 | <1% | 42 | $521.13 | |
| 82565 | <1% | 339 | $518.72 | |
| 87070 | <1% | 264 | $504.57 | |
| J9267 | Injection, paclitaxel, 1 mg | <1% | 36 | $501.56 |
| 73590 | <1% | 41 | $491.62 | |
| 80074 | <1% | 35 | $486.72 | |
| 72050 | <1% | 30 | $462.88 | |
| 86200 | <1% | 122 | $458.81 | |
| 92133 | <1% | 81 | $440.44 | |
| 83516 | <1% | 279 | $427.01 | |
| 73552 | <1% | 45 | $423.97 | |
| 83001 | <1% | 62 | $406.64 | |
| 86705 | <1% | 99 | $397.18 | |
| 84590 | <1% | 388 | $383.93 | |
| J3490 | Unclassified drugs | <1% | 235 | $383.38 |
| 87081 | <1% | 189 | $375.33 | |
| 86304 | <1% | 41 | $369.60 | |
| 87205 | <1% | 321 | $321.96 | |
| 87040 | <1% | 37 | $289.80 | |
| 84146 | <1% | 70 | $287.86 | |
| 86039 | <1% | 87 | $286.55 | |
| 87077 | <1% | 243 | $282.33 | |
| 86431 | <1% | 149 | $257.16 | |
| 86003 | <1% | 1,107 | $249.70 | |
| 82107 | <1% | 41 | $229.12 | |
| 85613 | <1% | 161 | $225.72 | |
| 85705 | <1% | 152 | $224.19 | |
| 73140 | <1% | 20 | $216.44 | |
| 84270 | <1% | 47 | $215.63 | |
| 87338 | <1% | 26 | $210.70 | |
| 86592 | <1% | 205 | $208.94 | |
| 73560 | <1% | 17 | $191.00 | |
| 82274 | <1% | 40 | $185.06 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $181.94 |
| 82785 | <1% | 92 | $180.96 | |
| 85732 | <1% | 124 | $176.71 | |
| 86665 | <1% | 27 | $149.44 | |
| 84134 | <1% | 78 | $130.42 | |
| 86644 | <1% | 41 | $129.80 | |
| 71045 | Radiologic examination, chest; single view | <1% | 17 | $128.75 |
| 82525 | <1% | 47 | $118.80 | |
| 82977 | <1% | 81 | $113.30 | |
| 82248 | <1% | 63 | $102.32 | |
| 84255 | <1% | 91 | $100.62 | |
| 84436 | <1% | 70 | $81.93 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,212 | $76.97 |
| 80164 | <1% | 18 | $64.65 | |
| 84154 | <1% | 16 | $64.20 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,477 | $51.38 |
| 82104 | <1% | 18 | $48.72 | |
| 81025 | <1% | 62 | $42.84 | |
| 82040 | <1% | 35 | $41.73 | |
| 94150 | <1% | 19 | $40.49 | |
| 87210 | <1% | 21 | $18.32 | |
| 86800 | <1% | 16 | $17.22 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 137 | $16.38 |
| 86376 | <1% | 14 | $4.09 | |
| 36591 | <1% | 293 | $1.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 396 | $0.00 |
| 0001A | 0% | 19 | $0.00 | |
| 86317 | 0% | 19 | $0.00 | |
| 0002A | 0% | 16 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 252 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 100 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELLIS, STEPHANIE (DIRECTOR, REVENUE INTEGRITY)